Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Dr. Reddy's Laboratories Ltd

NSE: DRREDDY · BSE: 500124 · Pharmaceuticals & Biotechnology · 45 announcements

Dr. Reddy's Laboratories Ltd news stories on ALFA NewsRead the news →
Share price
₹1,198.10
Market cap
₹1,00,003 Cr
Revenue (annual)
₹33,700 Cr
Net profit (annual)
₹4,196 Cr
P/E (TTM)
31.0×Sector 47.4×
Promoter holding
26.64%+0.01% QoQ
FII holding
20.67%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:16 IST BSE
Other Announcement

Dr. Reddy's Laboratories Other Announcement

Dr Reddys Laboratories Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing details holdings of promoters, institutions, and public shareholders.

20:00 IST BSE
Other Announcement

Dr. Reddy's Laboratories Other Announcement

Dr. Reddy's sent letters to shareholders providing a link to the FY 2025-26 Integrated Annual Report. The notice includes details for the 42nd AGM.

16:38 IST BSE
Other Announcement

Dr. Reddy's Laboratories Other Announcement

Dr. Reddy's Laboratories submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The independent report confirms regulatory compliance with no significant deviations.

15:29 IST BSE
Other Announcement

Dr. Reddy's Laboratories Other Announcement

Dr. Reddy's senior management will ring the NYSE Closing Bell on May 29, 2026. The ceremony celebrates the company's 25th anniversary of listing on the exchange.